Home/AbbVie/Jeffrey Ryan Stewart
JR

Jeffrey Ryan Stewart

Executive Vice President, Chief Commercial Officer

AbbVie

AbbVie Pipeline

DrugIndicationPhase
Humira (adalimumab)Rheumatoid arthritis, psoriasis, IBDApproved
Skyrizi (risankizumab)Psoriasis, Crohn's diseaseApproved
Rinvoq (upadacitinib)Rheumatoid arthritis, atopic dermatitisApproved
Imbruvica (ibrutinib)Blood cancersApproved
Venclexta (venetoclax)CLL, AMLApproved
Orilissa (elagolix)EndometriosisApproved
ABBV-951Parkinson's diseasePhase 3
ABBV-383Multiple myelomaPhase 1/2